Open AccessContinuous transformation of chiral pharmaceuticals in enzymatic membrane bioreactors for advanced wastewater treatment
Author(s) -
Luong N. Nguyen,
Faisal I. Hai,
James A. McDonald,
Stuart J. Khan,
William E. Price,
Long D. Nghiem
Publication year - 2017
Publication title -
water science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.406
H-Index - 137
eISSN - 1996-9732
pISSN - 0273-1223
DOI - 10.2166/wst.2017.331
Subject(s) - bioreactor , membrane bioreactor , transformation (genetics) , wastewater , enzyme , chemistry , chromatography , sewage treatment , membrane , pulp and paper industry , waste management , biochemistry , organic chemistry , engineering , gene
This study demonstrates continuous enantiomeric inversion and further biotransformation of chiral profens including ibuprofen, naproxen and ketoprofen by an enzymatic membrane bioreactor (EMBR) dosed with laccase. The EMBR showed non-enantioselective transformations, with high and consistent transformation of both (R)- and (S)-ibuprofen (93 ± 6%, n = 10), but lower removals of both enantiomers of naproxen (46 ± 16%, n = 10) and ketoprofen (48 ± 17%, n = 10). Enantiomeric analysis revealed a bidirectional but uneven inversion of the profens, for example 14% inversion of (R)- to (S)- compared to 4% from (S)- to (R)-naproxen. With redox-mediator addition, the enzymatic chiral inversion of both (R)- and (S)-profens remained unchanged, although the overall conversion became enantioselective; except for (S)-naproxen, the addition of redox mediator promoted the degradation of (R)-profens only.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom